The oxford laser prostate trial: Sensitivity to change of three measures of outcome

To evaluate the sensitivity to change of outcome measures in a double-blind randomized controlled trial of transurethral resection of the prostate (TURP) and contact laser prostatectomy. A total of 152 patients were randomized to TURP or contact laser prostatectomy using the Surgical Laser Technolog...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Urology (Ridgewood, N.J.) N.J.), 1996, Vol.47 (1), p.43-47
Hauptverfasser: Keoghane, S.R., Lawrence, K.C., Jenkinson, C.P, Doll, H.A., Chappel, D.B., Cranston, D.W.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 47
container_issue 1
container_start_page 43
container_title Urology (Ridgewood, N.J.)
container_volume 47
creator Keoghane, S.R.
Lawrence, K.C.
Jenkinson, C.P
Doll, H.A.
Chappel, D.B.
Cranston, D.W.
description To evaluate the sensitivity to change of outcome measures in a double-blind randomized controlled trial of transurethral resection of the prostate (TURP) and contact laser prostatectomy. A total of 152 patients were randomized to TURP or contact laser prostatectomy using the Surgical Laser Technology (SLT) system. Preoperative data were obtained using a self-administered questionnaire containing the American Urological Association (AUA-7) symptom score, the bothersome score (benign prostatic hyperplasia impact index) and the Short Form-36 health status questionnaire (SF-36). Follow-up was at 1 and 3 months. Effect size scores were calculated to indicate the extent of change from baseline to follow-up. Data were available on 148 patients: 72 received laser therapy and 76 received TURP. Mean change in AUA-7 score at 3 months was 7.3 in the laser arm, compared with 11.9 in the TURP arm ( P < 0.05). Furthermore, substantial change was detected in both groups on the bothersome score. However, very few significant differences in SF-36 dimension scores from baseline to 3 months were detected. The SF-36 at both baseline and follow-up indicated a similar level of health status as that reported in the general population. Subsequently, the measure did not improve on any dimensions. Our data support the claim of some researchers that shorter disease-specific indices are vital to the evaluation of treatment regimens in clinical trials, especially when the general health of the patients is similar to that of the population.
doi_str_mv 10.1016/S0090-4295(99)80380-X
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_77970058</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S009042959980380X</els_id><sourcerecordid>77970058</sourcerecordid><originalsourceid>FETCH-LOGICAL-c389t-678e177d82a6d2fba3034bda6faa6ff8dd516f2bf80cab1b17a115b66d8f9a163</originalsourceid><addsrcrecordid>eNqFkE1LXDEUhkOp2Kn2JwhZiLSLq8m9c_PhRorYKghdjAV34dzkpJNyPzTJFf33zTjDbLsICTnPe3LyEHLC2TlnXFysGNOsWta6_ar1N8UaxarHD2TB21pWWuv2I1nskU_kc0p_GWNCCHlIDlUrypEvyOphjXR69VN0tIeEkT7FKWXISHMM0F_SFY4p5PAS8hvNE7VrGP-UiKd5HRHpgJDmiGlzM83ZTgMekwMPfcIvu_2I_P5x83B9W93_-nl3_f2-so3SuRJSIZfSqRqEq30HDWuWnQPhoSyvnGu58HXnFbPQ8Y5L4LzthHDKa-CiOSJn275l5OcZUzZDSBb7Hkac5mSk1JKxVhWw3YK2_C1F9OYphgHim-HMbGSad5lmY8pobd5lmseSO9k9MHcDun1qZ6_UT3d1SBZ6H2G0Ie2xWstaN8uCXW0xLDJeAkaTbMDRogsRbTZuCv8Z5B-FopJQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>77970058</pqid></control><display><type>article</type><title>The oxford laser prostate trial: Sensitivity to change of three measures of outcome</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Keoghane, S.R. ; Lawrence, K.C. ; Jenkinson, C.P ; Doll, H.A. ; Chappel, D.B. ; Cranston, D.W.</creator><creatorcontrib>Keoghane, S.R. ; Lawrence, K.C. ; Jenkinson, C.P ; Doll, H.A. ; Chappel, D.B. ; Cranston, D.W.</creatorcontrib><description>To evaluate the sensitivity to change of outcome measures in a double-blind randomized controlled trial of transurethral resection of the prostate (TURP) and contact laser prostatectomy. A total of 152 patients were randomized to TURP or contact laser prostatectomy using the Surgical Laser Technology (SLT) system. Preoperative data were obtained using a self-administered questionnaire containing the American Urological Association (AUA-7) symptom score, the bothersome score (benign prostatic hyperplasia impact index) and the Short Form-36 health status questionnaire (SF-36). Follow-up was at 1 and 3 months. Effect size scores were calculated to indicate the extent of change from baseline to follow-up. Data were available on 148 patients: 72 received laser therapy and 76 received TURP. Mean change in AUA-7 score at 3 months was 7.3 in the laser arm, compared with 11.9 in the TURP arm ( P &lt; 0.05). Furthermore, substantial change was detected in both groups on the bothersome score. However, very few significant differences in SF-36 dimension scores from baseline to 3 months were detected. The SF-36 at both baseline and follow-up indicated a similar level of health status as that reported in the general population. Subsequently, the measure did not improve on any dimensions. Our data support the claim of some researchers that shorter disease-specific indices are vital to the evaluation of treatment regimens in clinical trials, especially when the general health of the patients is similar to that of the population.</description><identifier>ISSN: 0090-4295</identifier><identifier>EISSN: 1527-9995</identifier><identifier>DOI: 10.1016/S0090-4295(99)80380-X</identifier><identifier>PMID: 8560661</identifier><identifier>CODEN: URGYAZ</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Biological and medical sciences ; Double-Blind Method ; Follow-Up Studies ; Humans ; Laser Therapy ; Male ; Medical sciences ; Prostatectomy - methods ; Sensitivity and Specificity ; Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases ; Surgery of the urinary system ; Time Factors</subject><ispartof>Urology (Ridgewood, N.J.), 1996, Vol.47 (1), p.43-47</ispartof><rights>1996</rights><rights>1996 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c389t-678e177d82a6d2fba3034bda6faa6ff8dd516f2bf80cab1b17a115b66d8f9a163</citedby><cites>FETCH-LOGICAL-c389t-678e177d82a6d2fba3034bda6faa6ff8dd516f2bf80cab1b17a115b66d8f9a163</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S009042959980380X$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3536,4009,27902,27903,27904,65309</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=2972934$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8560661$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Keoghane, S.R.</creatorcontrib><creatorcontrib>Lawrence, K.C.</creatorcontrib><creatorcontrib>Jenkinson, C.P</creatorcontrib><creatorcontrib>Doll, H.A.</creatorcontrib><creatorcontrib>Chappel, D.B.</creatorcontrib><creatorcontrib>Cranston, D.W.</creatorcontrib><title>The oxford laser prostate trial: Sensitivity to change of three measures of outcome</title><title>Urology (Ridgewood, N.J.)</title><addtitle>Urology</addtitle><description>To evaluate the sensitivity to change of outcome measures in a double-blind randomized controlled trial of transurethral resection of the prostate (TURP) and contact laser prostatectomy. A total of 152 patients were randomized to TURP or contact laser prostatectomy using the Surgical Laser Technology (SLT) system. Preoperative data were obtained using a self-administered questionnaire containing the American Urological Association (AUA-7) symptom score, the bothersome score (benign prostatic hyperplasia impact index) and the Short Form-36 health status questionnaire (SF-36). Follow-up was at 1 and 3 months. Effect size scores were calculated to indicate the extent of change from baseline to follow-up. Data were available on 148 patients: 72 received laser therapy and 76 received TURP. Mean change in AUA-7 score at 3 months was 7.3 in the laser arm, compared with 11.9 in the TURP arm ( P &lt; 0.05). Furthermore, substantial change was detected in both groups on the bothersome score. However, very few significant differences in SF-36 dimension scores from baseline to 3 months were detected. The SF-36 at both baseline and follow-up indicated a similar level of health status as that reported in the general population. Subsequently, the measure did not improve on any dimensions. Our data support the claim of some researchers that shorter disease-specific indices are vital to the evaluation of treatment regimens in clinical trials, especially when the general health of the patients is similar to that of the population.</description><subject>Biological and medical sciences</subject><subject>Double-Blind Method</subject><subject>Follow-Up Studies</subject><subject>Humans</subject><subject>Laser Therapy</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Prostatectomy - methods</subject><subject>Sensitivity and Specificity</subject><subject>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</subject><subject>Surgery of the urinary system</subject><subject>Time Factors</subject><issn>0090-4295</issn><issn>1527-9995</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkE1LXDEUhkOp2Kn2JwhZiLSLq8m9c_PhRorYKghdjAV34dzkpJNyPzTJFf33zTjDbLsICTnPe3LyEHLC2TlnXFysGNOsWta6_ar1N8UaxarHD2TB21pWWuv2I1nskU_kc0p_GWNCCHlIDlUrypEvyOphjXR69VN0tIeEkT7FKWXISHMM0F_SFY4p5PAS8hvNE7VrGP-UiKd5HRHpgJDmiGlzM83ZTgMekwMPfcIvu_2I_P5x83B9W93_-nl3_f2-so3SuRJSIZfSqRqEq30HDWuWnQPhoSyvnGu58HXnFbPQ8Y5L4LzthHDKa-CiOSJn275l5OcZUzZDSBb7Hkac5mSk1JKxVhWw3YK2_C1F9OYphgHim-HMbGSad5lmY8pobd5lmseSO9k9MHcDun1qZ6_UT3d1SBZ6H2G0Ie2xWstaN8uCXW0xLDJeAkaTbMDRogsRbTZuCv8Z5B-FopJQ</recordid><startdate>1996</startdate><enddate>1996</enddate><creator>Keoghane, S.R.</creator><creator>Lawrence, K.C.</creator><creator>Jenkinson, C.P</creator><creator>Doll, H.A.</creator><creator>Chappel, D.B.</creator><creator>Cranston, D.W.</creator><general>Elsevier Inc</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>1996</creationdate><title>The oxford laser prostate trial: Sensitivity to change of three measures of outcome</title><author>Keoghane, S.R. ; Lawrence, K.C. ; Jenkinson, C.P ; Doll, H.A. ; Chappel, D.B. ; Cranston, D.W.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c389t-678e177d82a6d2fba3034bda6faa6ff8dd516f2bf80cab1b17a115b66d8f9a163</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1996</creationdate><topic>Biological and medical sciences</topic><topic>Double-Blind Method</topic><topic>Follow-Up Studies</topic><topic>Humans</topic><topic>Laser Therapy</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Prostatectomy - methods</topic><topic>Sensitivity and Specificity</topic><topic>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</topic><topic>Surgery of the urinary system</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Keoghane, S.R.</creatorcontrib><creatorcontrib>Lawrence, K.C.</creatorcontrib><creatorcontrib>Jenkinson, C.P</creatorcontrib><creatorcontrib>Doll, H.A.</creatorcontrib><creatorcontrib>Chappel, D.B.</creatorcontrib><creatorcontrib>Cranston, D.W.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Urology (Ridgewood, N.J.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Keoghane, S.R.</au><au>Lawrence, K.C.</au><au>Jenkinson, C.P</au><au>Doll, H.A.</au><au>Chappel, D.B.</au><au>Cranston, D.W.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The oxford laser prostate trial: Sensitivity to change of three measures of outcome</atitle><jtitle>Urology (Ridgewood, N.J.)</jtitle><addtitle>Urology</addtitle><date>1996</date><risdate>1996</risdate><volume>47</volume><issue>1</issue><spage>43</spage><epage>47</epage><pages>43-47</pages><issn>0090-4295</issn><eissn>1527-9995</eissn><coden>URGYAZ</coden><abstract>To evaluate the sensitivity to change of outcome measures in a double-blind randomized controlled trial of transurethral resection of the prostate (TURP) and contact laser prostatectomy. A total of 152 patients were randomized to TURP or contact laser prostatectomy using the Surgical Laser Technology (SLT) system. Preoperative data were obtained using a self-administered questionnaire containing the American Urological Association (AUA-7) symptom score, the bothersome score (benign prostatic hyperplasia impact index) and the Short Form-36 health status questionnaire (SF-36). Follow-up was at 1 and 3 months. Effect size scores were calculated to indicate the extent of change from baseline to follow-up. Data were available on 148 patients: 72 received laser therapy and 76 received TURP. Mean change in AUA-7 score at 3 months was 7.3 in the laser arm, compared with 11.9 in the TURP arm ( P &lt; 0.05). Furthermore, substantial change was detected in both groups on the bothersome score. However, very few significant differences in SF-36 dimension scores from baseline to 3 months were detected. The SF-36 at both baseline and follow-up indicated a similar level of health status as that reported in the general population. Subsequently, the measure did not improve on any dimensions. Our data support the claim of some researchers that shorter disease-specific indices are vital to the evaluation of treatment regimens in clinical trials, especially when the general health of the patients is similar to that of the population.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>8560661</pmid><doi>10.1016/S0090-4295(99)80380-X</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0090-4295
ispartof Urology (Ridgewood, N.J.), 1996, Vol.47 (1), p.43-47
issn 0090-4295
1527-9995
language eng
recordid cdi_proquest_miscellaneous_77970058
source MEDLINE; Elsevier ScienceDirect Journals
subjects Biological and medical sciences
Double-Blind Method
Follow-Up Studies
Humans
Laser Therapy
Male
Medical sciences
Prostatectomy - methods
Sensitivity and Specificity
Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases
Surgery of the urinary system
Time Factors
title The oxford laser prostate trial: Sensitivity to change of three measures of outcome
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T00%3A56%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20oxford%20laser%20prostate%20trial:%20Sensitivity%20to%20change%20of%20three%20measures%20of%20outcome&rft.jtitle=Urology%20(Ridgewood,%20N.J.)&rft.au=Keoghane,%20S.R.&rft.date=1996&rft.volume=47&rft.issue=1&rft.spage=43&rft.epage=47&rft.pages=43-47&rft.issn=0090-4295&rft.eissn=1527-9995&rft.coden=URGYAZ&rft_id=info:doi/10.1016/S0090-4295(99)80380-X&rft_dat=%3Cproquest_cross%3E77970058%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=77970058&rft_id=info:pmid/8560661&rft_els_id=S009042959980380X&rfr_iscdi=true